FDA Oncology Announcements

Erythrocyte growth factor × Other × Clear all

2 Announcements

FDA approves Retacrit as a biosimilar to Epogen/Procrit

Drug: Retacrit (epoetin alfa-epbx) · Erythrocyte growth factor
Condition: Classical hematology

Erythropoiesis-stimulating Agents (ESAs)

Drugs: Aranesp (darbepoetin alfa) · Erythrocyte growth factor, Epogen (epoetin alfa) · Erythrocyte growth factor
Condition: Other